Episode 67: Deep peptide recognition profiling decodes TCR specificity and enables disease-associated antigen discovery

About this episode

The episode discusses a study on T cell receptor specificity and its implications for autoimmune disease identification.

**Monday Immune Engager** — our weekly pick from the latest immune-engager digest. **Paper:** [Deep peptide recognition profiling decodes TCR specificity and enables disease-associated antigen discovery](https://doi.org/10.1038/s41587-026-03128-x) **Authors:** Nan Wang, Hugh Yeh, Ben Lai, Jason Perera, Kevin M. Jude, et al. **Journal:** Nature Biotechnology, 2026 **Why it matters:** Mapping how T cell receptors actually recognize peptides — rather than inferring it from sequence alone — opens a scalable path to identifying the self-antigens driving autoimmune diseases like ankylosing spondylitis. **Summary** Predicting what a T cell receptor (TCR) will recognize based on its amino acid sequence is notoriously unreliable: nearly identical TCRs can bind completely different antigens, while structurally dissimilar TCRs can converge on the same target. To attack this problem directly, the authors focused on a clinically defined set of HLA-B\*27:05-restricted TCRs from patients with ankylosing spondylitis (a disease causing spinal fusion) and acute anterior uveitis (severe inflammatory eye disease). They used high-throughput yeast display — engineering yeast to present roughly one…

People in this episode

Host: Raymond Ruff

Topics covered

• T cell receptors
• peptide recognition
• autoimmune diseases
• high-throughput screening
• disease-associated antigens

Keywords

• TCR specificity
• peptide recognition profiling
• autoimmune diseases
• ankylosing spondylitis
• high-throughput yeast display

Mentioned in this episode

Organizations: Nature Biotechnology, HLA-B*27:05

More episodes of Science TLDR

• Episode 75: Trending — A 5.3-million-year-old deep-sea whale necropolis in the Diamantina Zone · June 12, 2026 · 19 min
• Episode 74: Discovery of TCR-like antibodies to the KRAS G12D neoantigen via in silico-in vitro workflow · June 9, 2026 · 12 min
• Episode 73: Trending — Work from Home and Disability Employment · June 5, 2026 · 23 min
• Episode 72: From free speech advocates to critics: The Trump administration’s new rhetoric promotes support for censorship among Trump voters · June 2, 2026 · 19 min
• Episode 71: MAGE-A4/MAGE-A8-targeted TCR-based bispecific T cell engager in recurrent and/or refractory solid tumors: a phase 1 trial · June 1, 2026 · 22 min
• Episode 70: Language Modeling Materializes a World Model of Protein Biology · May 27, 2026 · 20 min